Treatment-Resistant Depression Entering Remission Following a Seizure during the Course of Repetitive Transcranial Magnetic Stimulation

Major depressive disorder is often resistant to antidepressant treatment. Repetitive transcranial magnetic stimulation (rTMS) has been used in treatment-resistant depression (TRD). Known adverse events of rTMS include transient headache, local pain, syncope, seizure induction, and hypomania inductio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ju-Wan, Bae, Kyung-Yeol, Kim, Sung-Wan, Kang, Hee-Ju, Shin, Il-Seon, Yoon, Jin-Sang, Kim, Jae-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965659/
https://www.ncbi.nlm.nih.gov/pubmed/27482250
http://dx.doi.org/10.4306/pi.2016.13.4.468
Descripción
Sumario:Major depressive disorder is often resistant to antidepressant treatment. Repetitive transcranial magnetic stimulation (rTMS) has been used in treatment-resistant depression (TRD). Known adverse events of rTMS include transient headache, local pain, syncope, seizure induction, and hypomania induction. This report outlines a patient with TRD who unexpectedly improved following a seizure during the course of rTMS, which has never been reported.

Ejemplares similares